Pneumonia, Pneumococcal Therapeutic Market Size
Market Size in USD Bn
CAGR8.6%
| Study Period | 2025-2032 |
| Base Year of Estimation | 2024 |
| CAGR | 8.6% |
| Market Concentration | Medium |
| Major Players | Biotest AG, Vaxcyte, Inc., Merck & Co., Inc., Pfizer Inc., GlaxoSmithKline plc. and Among Others |
*Disclaimer: Major players are listed in no particular order.
*Source: Coherent Market Insights
Want to purchase customized report?
please let us know !
please let us know !
Pneumonia, Pneumococcal Therapeutic Market Analysis
The pneumonia, pneumococcal therapeutic market is estimated to be valued at USD 2.95 Billion in 2025 and is expected to reach USD 5.26 Billion by 2032, growing at a compound annual growth rate (CAGR) of 8.6% from 2025 to 2032. The growing geriatric population and increased risk of pneumonia among the elderly is driving the demand. Furthermore, rising pollution levels and environmental factors leading to higher prevalence of respiratory illnesses are also boosting the market growth.